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Lower back pain (LBP) is the most common musculo­
skeletal problem seen by general practitioners and 
remains the most common cause of disability in US 
patients <45 years of age.[1­3] It is the most expensive 
benign condition in industrialised countries owing to 
the number of work days lost. LBP, by definition, includes pain below 
the costal margin but above the inferior gluteal folds.[1­3] Definitions 
are given in Table 1. These include pain with and without non­
neuropathic leg pain. Various studies have indicated that 80% of US 
adults experience LBP in their lifetime.[3,4] In clinical practice, most 
practitioners have a superficial approach to this important clinical 
problem. Specific causes for LBP are uncommon and account for 
<15% of all such cases. In 85% of cases LBP is nonspecific; it will 
improve within 6 weeks, irrespective of treatment.  
The medical practitioner should try to establish whether the pain is 
mechanical or inflammatory. This distinction can often be made with 
the use of ‘diagnostic red flags’ (Table 2). Mechanical (nonspecific) 
LBP includes orthopaedic and neurosurgical causes, which may 
require surgical intervention. Epidemiological evidence suggests 
several risk factors for the development of LBP, including smoking, 
obesity and physically strenuous work. However, sedentary work 
and psychologically taxing work are also risk factors. Inflammatory 
back pain (IBP) is the hallmark symptom of spondyloarthritis. The 
features of IBP are listed in Table 3.
Assessment of a patient with lower 
back pain
There are multiple causes for LBP. It is important to note, however, 
that in a primary care setting the majority of patents have nonspecific 
LBP. Some important causes are outlined in Table 4. 
The physical examination of the patient with LBP is important 
to distinguish benign from more serious causes of the pain. This 
includes inspection of the spine from multiple angles. Palpate 
along the spine for tenderness or abnormal ‘steps’, sometimes 
indicative of spondylolisthesis. The assessment of movement of 
the spine includes flexion, extension and lateral and rotational 
movement in two directions. A straight leg­raising test with the 
patient supine is deemed positive if pain is elicited between 10° and 
60° and is indicative of compression at L4/L5. The Schober test is 
also important to assess the flexibility of the lumbar spine, which 
essentially measures stretch of the spine rather than the flexion angle 
(Fig. 1). The ‘capsular pattern’ of limitation at the lumbar spine is 
characterised by a limitation of movement in all planes, while at 
the neck flexion is usually not affected. This pattern of limitation 
of movement is generally associated with IBP. Mechanical causes of 
LBP will usually only limit movement in one plane. A discrepancy 
between the physi cal findings and anatomical or physiological 
principles is a way of identifying patients with major psychological 
factors. This should alert the clinician to the ‘yellow flags’ (Table 5).  
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Table 1. Definitions
• Acute lower back pain: an episode of lower back pain that resolves 
within 6 weeks 
• Subacute lower back pain: pain persisting for 6 ­ 12 weeks 
• Chronic lower back pain: persistent pain >12 weeks 
• Nonspecific lower back pain: pain not attributed to recognisable or 
known pathology, e.g. infection, fracture
Table 2. Red flags in lower back pain
• Pain in patients <20 years and >55 years 
• Pain not relieved on rest or posture modification 
• Pain unchanged despite 2 ­ 4 weeks of treatment 
• History of malignancy
• Immunosuppressed status
• Fever/malaise/weight loss
• High fracture risk, e.g. osteoporosis
• Neurological impairment
• Bladder or bowel dysfunction
• Severe morning stiffness as the primary complaint
• Inability to ambulate 
Table 3. Features of inflammatory back pain 
• Insidious onset 
• Age <45 years
• Nocturnal pain 
• Alternating buttock pain
• Pain with associated early morning stiffness lasting >1 hour
• Pain not relieved by rest
• Pain improving with exercise or activity
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Imaging 
Appropriate imaging of the spine is an essen­
tial part of the evaluation when a specific 
cause of LBP is suspected. Anteroposterior 
and lateral plain radiographs are helpful in 
assessing gross bone density, disc and vertebral 
body height and alignment. These should 
include a view of the pelvis. The characteristic 
radiographic feature of IBP is the presence of 
sacro­iliitis (Fig. 2). The classification criteria 
for ankylosing spondylitis (AS) are heavily 
weighted on the finding of sacro­iliitis on 
radiography.[5] However, recent evidence has 
demonstrated that radiographs are not sensitive 
in the detection of early sacro­iliitis and newer 
criteria include other imaging modalities, 
such as computed tomography (CT) scanning 
and magnetic resonance imaging (MRI), to 
diagnose IBP (non­radiographic inflammatory 
back pain).[6] CT scanning is effective for 
assess ing foraminal and extraforaminal 
nerve roots. It is thus most helpful if bony 
pathology is suspected. MRI is superior to CT 
for spinal imaging, but is more expensive. It 
is very effective for spinal cord or soft­tissue 
imaging, especially to diagnose sacro­iliitis. 
Other features of IBP include the presence 
of syndesmophytes, representing calcification 
of the spinal ligaments and culminating in 
the ‘bamboo’ spine, characteristic of long­
standing AS. There may also be ankylosis of 
the posterior components of the vertebrae, 
and ultimately neglected patients with AS will 
develop a ‘question mark posture’.
While the spondyloarthritides character­
istically affect the spine, there are situations 
where the inflammation affects the entheses 
around peripheral joints rather than those 
around the spine (peripheral spondylo­
arthritis).[6] This is often the case in reactive 
arthritis, where plantar fasciitis leads to 
development of a calcaneal spur, and 
Achilles tendinitis results in calcification 
of the Achilles tendon insertion (enthesis). 
Psoriatic arthritis usually affects the peri­
pheral joints rather than the sacro­iliac 
joint. Spondyloarthritides, other than AS, 
often results in unilateral sacro­iliitis. Tuber­
culosis (TB) is an important cause of the 
latter included in the differential diagnosis. 
There is a strong relationship between the 
presence of HLA B27 and sacro­iliitis in 
patients with spondyloarthritis.[5,6]
Approach to 
management 
Therapy or management of chronic LBP 
involves a multidisciplinary approach. The 
aim is to prevent a chronic vicious cycle by 
means of positive changes in the patient’s 
beliefs, coping mechanism and physical 
ability. The team employs pharmacological 
and non­pharmacological strategies to 
realise the goal.  
Fig. 2. Radiograph of patient with sacro-iliitis.
Table 4. Important causes of lower back pain
Mechanical Neurological Systemic
Disc herniation Radiculopathy Inflammatory 
spondyloarthropathy
Spinal canal stenosis Myelopathy Metabolic bone diseases
Disc and segmental degradation, 
e.g. facet arthropathy
Neuropathy Neoplasia, including myeloma
Soft­tissue injuries Myopathy Infections of bone, disc or 
epidura
Lumbosacral plexopathy Referred pain
Fig. 1. The Schober test.
Table 5. Yellow flags
• Dissociation between verbal and non­verbal pain behaviour
• Compensable cause of injury
• Psychological or emotional factors, e.g. depression, anxiety, abusive relationships 
• Narcotic drug requests 
• Repeated failure of both medical and surgical therapy 
• Disability or inability to return to work (unwillingness)
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Worldwide, the most commonly prescribed drugs for nonspecific 
LBP are the non­steroidal anti­inflammatory drugs (NSAIDs). There 
is evidence that they are more efficacious than placebo in the 
short term.[7] Because of their side­effects, it is recommended 
that in chronic LBP they should be used for short periods during 
pain exacerbations only. The best available evidence recommends 
the use of both analgesia and an antidepressant in nonspecific 
(mechanical) chronic LBP. The most widely studied are the tricyclic 
antidepressants. They modulate pain sensation through blockage of 
the reuptake of neurotransmitters.
Non­pharmacological therapy includes information and 
reassurance. This is an essential component of therapy. The use of the 
biopsychosocial model to change a patient’s beliefs around chronic 
LBP is important. Exercise therapy and avoidance of bed rest are also 
part of the management of LBP. Cognitive and behavioural therapy 
are helpful to change the patient’s response to pain.
In the treatment of IBP the goal is to suppress the inflammation 
of the enthesis in an effort to prevent calcification, probably as a 
healing response after inflammation. Regular use of NSAIDs has 
been shown to prevent syndesmophyte formation.[8] The current 
recommendation for the treatment of AS is that continuation of 
symptoms with persistent elevation of inflammatory markers after 3 
months of NSAID use is an indication for specific targeted therapy 
against tumour necrosis factor (TNF).[9] These agents are highly 
effective, but extremely expensive, making them unavailable for 
general use. Another disadvantage of this class of therapy is the risk 
of reactivating latent TB.
Summary
Chronic LBP is a common condition, usually with a nonspecific cause. A 
diagnostic algorithm can be used to identify patients with non­mechanical 
back pain. The assessment should also include prognostic yellow flags to 
identify patients who are at risk. It is very important to differentiate IBP 
and to identify its cause. The management of such patients involves a 
multidisciplinary team approach, employing pharmacological and non­
pharmacological strategies. IBP management has advanced considerably 
in recent years and usually requires the regular use of NSAIDs. Biological 
monoclonal antibodies directed against TNF should be used if NSAIDs 
have not resulted in improvement within 3 months and there is persistent 
elevation of inflammatory markers.
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